PE Anti-Human CD22 Antibody[BU59]

The PE Anti-Human CD22 Antibody[BU59] is a highly reliable and efficient product designed for the specific detection and analysis of CD22 protein expression in human samples. This antibody, conjugated with phycoerythrin (PE), offers exceptional sensitivity and specificity, ensuring accurate and precise results.

The CD22 protein, also known as Siglec-2, is a transmembrane glycoprotein primarily expressed on B cells. It plays a crucial role in regulating B cell activation and survival, making it a valuable target for research in immunology and oncology. The PE Anti-Human CD22 Antibody[BU59] enables researchers to investigate the expression and function of CD22 in various biological contexts.

This antibody has been meticulously developed and rigorously validated to ensure optimal performance. It exhibits minimal background noise and provides consistent and reproducible results, making it an ideal tool for flow cytometry and other immunological techniques. The PE conjugation enhances the signal intensity, facilitating the detection of low-abundance CD22 molecules.

The PE Anti-Human CD22 Antibody[BU59] is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming preparations. It is compatible with a wide range of sample types, including peripheral blood, bone marrow, and lymphoid tissues. The antibody is suitable for both research and diagnostic applications, enabling scientists and clinicians to gain valuable insights into B cell biology and related diseases.

In summary, the PE Anti-Human CD22 Antibody[BU59] is a highly reliable and efficient tool for the specific detection and analysis of CD22 protein expression. With its exceptional sensitivity, specificity, and ease of use, this antibody is an invaluable asset for researchers and clinicians in the fields of immunology and oncology.